DEI in precision medicine: successes, challenges and paths ahead
Advancements in DNA sequencing technologies have enabled a new era in precision medicine. However, our current DNA databases do not represent the diversity of human species. If we don’t increase genomics' access to underrepresented populations, we run the risk of adding to current health inequities. Thus, progress of precision medicine in the genomics era will depend on enrolling diverse populations in research. In this webinar, we will discuss current strategies, recent success and the road ahead at both national and state level to move towards a more diverse, equitable and inclusive precision medicine initiative.
Speakers
Ankita Arora, Moderator
University of Colorado Anschutz Medical Campus
Martin Mendoza
Director of health equity and health science policy, All of Us Research Program
Julianne McCall
Co-director, California Initiative to Advance Precision Medicine
Calais Prince
Associate director of science and health policy, American Association for Cancer Research
